Log in to search using one of your social media accounts:

 

FDA revises label on opioid cold meds to limit pediatric use

The FDA this week announced that it’s mandating labeling changes to cut the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in kids under 18 years of age. The agency wrote in a statement that the risks of these drugs outweigh their potential benefits for children. The medications will also receive an expanded Boxed Warning notifying users about the risks of abuse, addiction and death. Get the full story at our sister site, Drug Delivery Business News. The post FDA revises label on opioid cold meds to limit pediatric use appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Food & Drug Administration (FDA) Pediatrics Pharmaceuticals Respiratory Source Type: news

Related Links:

This study investigated the prevalence of drug use and the drug use behavior among people living with HIV in Hong Kong. In this cross-sectional survey, subjects were recruited by convenience sampling from the out-patient clinic of a HIV treatment center. A total of 500 subjects completed the questionnaire between January and May 2017. About one third (31.4%,n = 157) participants reported drug use behavior. Common substances used included methamphetamine (65%), rush poppers (59.2%), gamma-hydroxybutyrate (56.7%), ketamine (49%), ecstasy (45.9%), cannabis (34.4%), cocaine (18.5%), cough medicine (15.3%), and he...
Source: International Journal of Mental Health and Addiction - Category: Addiction Source Type: research
The U.S. Food and Drug Administration announced last month that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older. Labeling for the medications also is being updated with additional safety information fo...
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: From the FDA Source Type: research
Most of us are sanguine about the fact that some things are out of our control. We know, for example, that we can’t avoid death or taxes or do much about how tall we’ll grow. For much of everything else, we figure out a way to deal with what happens in life — until we can’t, for one reason or another. A prime example is the emotional upheaval caused by receiving an unexpected and scary medical or mental health diagnosis. Having gone through this myself recently, here are some ways to help you cope. Get all the facts. After the initial shock, take a few deep breaths and resolve to learn as much as yo...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Anxiety and Panic Grief and Loss Health-related Inspiration & Hope Motivation and Inspiration Cancer Chronic Illness Coping Skills health scare Medical Care Mental Illness Resilience Source Type: blogs
In the 19th century and early 20th century, class-A drugs were touted as medical cures. Lethal and addictive medical concoctions were unwittingly consumed by millions.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
The U.S. Food and Drug Administration announced today that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older. Labeling for the medications also is being updated with additional safety information for adu...
Source: Food and Drug Administration - Category: American Health Source Type: news
THURSDAY, Jan. 11, 2018 -- Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids. These...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Dear Shonda Rhimes, the brilliant mind behind my favorite television show, We need to talk about “Grey’s Anatomy.” I’m a fan. A really, really big fan. The kind of fan who — in the last 48 hours — rewatched all of last season’s episodes to prepare for the season premiere, and who has blocked off every Thursday night this fall to get lost in the drama at Grey Sloan Memorial. We all have our vices, and “Grey’s” is mine. But something occurred to me as I was bingeing on last season. From the lifesaving surgeries to the metastasized cancers, half of the plot lines and...
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Policy Mainstream media Primary Care Public Health & Source Type: blogs
During the 90-minute feature documentary “Steve McQueen: American Icon,” audiences will reflect on the career of the “King of Cool” and discover the untold true story of the star’s late-in-life spiritual quest. They will also learn about mesothelioma — the rare cancer that killed McQueen at age 50 — and the dangers of asbestos. A public service announcement featuring Asbestos Disease Awareness Organization (ADAO) president and co-founder Linda Reinstein and Barbara McQueen, Steve’s widow, will air before encore screenings of the documentary on Oct. 10 and Oct. 19. Tickets a...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: “Steve McQueen American Icon alternative cancer treatments Asbestos Disease Awareness Organization asbestos marines asbestos public service announcement Barbara McQueen Billy Grah born-again Christian dangers of asbestos Don Schoonover Source Type: news
This study examined psychiatric comorbidity in patients dependent on Z-drugs or BDZs attending substance abuse clinics in Hong Kong. In this retrospective chart review, the medical records of 207 patients (117 on Z-drugs and 90 on BDZs) treated between January 2008 and August 2012 were analysed. Demographic data, patterns of substance misuse and comorbid psychiatric diagnoses were recorded. Patients dependent on Z-drugs were younger (40.5  ± 10.4 vs. 46.8 ± 11.6;p 
Source: International Journal of Mental Health and Addiction - Category: Addiction Source Type: research
A 54-year-old heavy smoker was admitted with a 2-week history of pleuritic chest pain, cough, shortness of breath and weight loss. He had not improved despite a course of antibiotics from his general practitioner. He was commenced on intravenous antibiotics for presumed pneumonia based on his chest X-ray, which seemed to show left middle zone opacification (figure 1), and after 2 days, he was discharged with a further oral antibiotic course. Figure 1Posteroanterior chest X-ray showing pleural-based shadowing with cavitation abutting the left lateral chest wall with a characteristic convex ‘D’ shape of...
Source: Postgraduate Medical Journal - Category: General Medicine Authors: Tags: Journalology, General practice / family medicine, Drugs: infectious diseases, Pain (neurology), Alcohol-related disorders, Drugs misuse (including addiction), Radiology, Pneumonia (respiratory medicine), Clinical diagnostic tests, Cardiothoracic surgery, Source Type: research
More News: Addiction | Child Abuse | Children | Cough | Hydrocodone | Pediatrics | Respiratory Medicine | Substance Abuse | Warnings